𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High resolution microscopic mapping of DNA using multicolor fluorescent hybridization

✍ Scribed by Dr. Bradford Windle; Emilio Silvas; Irma Parra


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
661 KB
Volume
16
Category
Article
ISSN
0173-0835

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Optimization and automation of fluoresce
✍ Patrik Scholler; Steffen Heber; Dr. JΓΆrg D. Hoheisel πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 595 KB

Large-scale hybridization-based genome mapping projects, such as the production of sequence-ready physical clone maps, call for robust and cheap DNA labeling techniques that are amenable to automation. We routinely use a highthroughput protocol based on fluorescence detection. DNA probes are labeled

Characterization of amplicons in neurobl
✍ Anne Fix; Carlo Lucchesi; AgnΓ¨s Ribeiro; Delphine Lequin; GaΓ«lle Pierron; Gudrun πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

## Abstract Somatically acquired chromosomal imbalances are a key feature of neuroblastoma, a heterogeneous pediatric solid tumor. Among these alterations, genomic amplification targeting the __MYCN__ oncogene and observed in about 25–30% of the cases, strongly correlates with advanced stage and po

High-resolution analysis of 16q22.1 in b
✍ Emad A. Rakha; John A.L. Armour; Sarah E. Pinder; Claire E. Paish; Ian O. Ellis πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 565 KB

## Abstract Loss of the chromosomal material at 16q22.1 is one of the most frequent genetic aberrations found in both lobular and low‐grade nonlobular invasive carcinoma of the breast, indicating the presence of a tumour suppressor gene (TSG) at this region in these tumours. However, the TSG (s) at

Genomewide screening of DNA copy number
✍ Noriko Hosoya; Masashi Sanada; Yasuhito Nannya; Kumi Nakazaki; Lili Wang; Akira πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 251 KB

## Abstract Chronic myelogenous leukemia (CML) evolves from an indolent chronic phase (CP) characterized by the Philadelphia chromosome. Without effective therapy, it progresses to an accelerated phase (AP) and eventually to a fatal blast crisis (BC). To identify the genes involved in stage progres